Normalizovaný smoothness index a parametrický populační RDH index losartanu u pacientů s čerstvě zjištěnou hypertenzí a metabolickým syndromem.

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English The normalized smoothness index and parametric population RDH index of losartan in patients with newly diagnosed hypertension
Authors

ŘIHÁČEK Ivan FRÁŇA Petr SCHWARZ Daniel PLACHÝ Martin SOUČEK Miroslav

Year of publication 2010
Type Article in Periodical
Magazine / Source Vnitř. Lék.
MU Faculty or unit

Faculty of Medicine

Citation
Field Cardiovascular diseases incl. cardiosurgery
Keywords hypertension; metabolic syndrome; normalized smoothness index; RDH index; losartan
Description Aims of the study: To evaluate 24hour efficacy of losartan in patients with newly diagnosed hypertension and metabolic syndrome using the parametric population RDH index and normalized smoothness index. Patient sample and methodology: Eighteen men, 9 women, mean age of 48 years, body mass index of 32.6, before and after 1 year of therapy with losartan in the mean dose of 69 mg once a day. Results: The population normalized smoothness index of losartan (plus minus standard error of the mean) was 1.10 plus minus 0.13 for systolic pressure, 0.81 plus minus 0.10 for diastolic pressure and 1.00 plus minus 0.14 for mean arterial blood pressure. The parametric population RDH index of 24, 24, 0 for systolic pressure and 24, 24, 0 for diastolic pressure. Conclusion: Losartan at a mean dose of 69 mg once daily showed an adequate 24hour efficacy in patients with newly diagnosed hypertension and metabolic syndrome.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info